JPRN-UMIN000005523招募中未知
Effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease. - Carotid Atherosclerosis- Antihypertensive Treatment Trial, Effect of N-type CCB for cerebrovascular Disease (CA-ATTEND).
Ajinomoto Pharmaceuticals Co., LTD.0 个研究点目标入组 3,000 人开始时间: 2011年4月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant or possibly pregnant patients.
研究者
相似试验
招募中
不适用
Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysisendstage chronic kidney diseaseJPRN-UMIN000023201Department of Nephrology and Dialysis, Moriguchi Keijinnkai Hospital20
招募中
不适用
The effect of L/N type Calcium channel blocker on blood pressure variability in elderly hypertensive patientsHypertensionJPRN-UMIN000014843Osaka university graduate school of medicine The department of geriatric medicine and nephrology40
招募中
不适用
Evaluation of L/N type Ca2+ channel blocker (cilnidipine) in hypertension complicated diabetes or sleep apnea syndrome ; Trial for the effects of improvementof arteriosclerosis and renal function.Diabetes/Hypertension/Sleep apnea syndromeJPRN-UMIN000014635Kanazawa Medical Clinic50
招募中
不适用
Effect of an N/L-type Ca channel blocker on prorenin and soluble (pro)renin receptor levels in hypertensive patients: A randomized controlled trialEssential hypertensionJPRN-UMIN000016123Tokyo Women's Medical University100
已完成
4 期
Therapeutic effects of L/N type calcium channel blocker cilnidipine and L type calcium channel blockers on hypertensive patients with chronic kidney diseaseHypertension, Chronic kidney diseaseJPRN-UMIN000001593Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine60